![]() ![]() In 2018, the company transitioned from a flat subscription model to the current, fee-per-booking model that enabled it to lower the barrier to entry for providers, accelerating the growth of providers on its platform. We’ve been incredibly impressed by the pace of Zocdoc’s innovation and growth, as well as the company’s invaluable contributions to improving America’s healthcare system – including supporting the needs of patients amid the COVID-19 pandemic.” – Scott Eisenberg, Head of Credit and Structured Solutions at Francisco Partners. “Zocdoc is a remarkable company that is well positioned to be consumers’ one-stop-shop for all their healthcare needs, and we’re proud to work with them to fund their next chapter. ![]() I have never been more proud of the Zocdoc team or more excited about our future.” – Oliver Kharraz, M.D., Zocdoc founder and CEO. From our rapid expansion into telehealth to our efforts in helping cities and health systems distribute vaccines, our work remains focused on giving power to the patient. ![]() The last year has demonstrated that Zocdoc is poised to have a transformative impact on healthcare in this country. “Today, Zocdoc is the rarest type of private technology company: we are profitable with accelerating growth, and we are a business that does real good for the world. ![]() Zocdoc Vaccine Scheduler has been adopted by the City of Chicago and health systems around the country to help fast-track vaccinations. The company is offering this new solution free of charge to help accelerate public health efforts. This new service is designed to help cities, states, and healthcare providers centralize and streamline vaccinations. Most recently, the company introduced Zocdoc Vaccine Scheduler. The company provides online scheduling for both physical and virtual care services. New York-based digital healthcare marketplace ZocdocĪnnounced $150 million in growth financing from Francisco Partners, a global investment firm that specializes in partnering with technology businesses. ![]()
0 Comments
Leave a Reply. |